PVG Asset Management’s Boston Scientific BSX Stock Holding History

PVG Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,820	Closed	-$254K	–	35
2023 Q3	$254K	Buy	+4,820	New	+$253K	1.73%	15

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PVG Asset Management's BSX Position: Q4 2023 in Review

PVG Asset Management sold out of Boston Scientific (BSX) in Q4 2023, closing a stake of 4,820 shares — an estimated $254K sold.

PVG Asset Management first reported a position in BSX in Q3 2023 and held it in 1 quarter. The position peaked at $254K in Q3 2023. 1,148 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

PVG Asset Management reported no remaining Boston Scientific position as of Q4 2023 after selling out during the quarter.
PVG Asset Management sold 4,820 Boston Scientific shares in Q4 2023, an estimated $254K.
PVG Asset Management first reported a position in Boston Scientific in Q3 2023 and held it in 1 quarter.
PVG Asset Management's Boston Scientific position peaked at $254K in Q3 2023.
1,148 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on PVG Asset Management's 13F filing for Q4 2023, filed 12 Mar 2024.